Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1997-03-26
1997-12-02
Elliott, George C.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C07K 1447
Patent
active
056937598
ABSTRACT:
The invention provides methods and compositions relating to the Tax-response Complex-1 (TRC-1) a transcription complex associated with disease, particularly HTLV infection. TRC-1 is composed of novel forms of JunB and a member of a novel protein family called small nuclear factors or SNFs. The expression of these compounds are shown to correlate with cell lineage, activation and infection. SNFs and T-cell specific forms of JunB, find particular use in screening assays for agents or lead compounds for agents useful in the diagnosis, prognosis or treatment of disease, particularly HTLV infection. Nucleic acids encoding SNFs, and SNF-specific binding agents find use in diagnosis and as commercial reagents for the biopharmaceutical industry.
REFERENCES:
Jones et al., PNAS(USA), May, 1992, vol. 89: pp. 4042-4046.
Klump Wolfgang
Martin Tracy
Wachsman William
Elliott George C.
McKelvey Terry A.
Osman Richard Aron
Regents of the University of California
LandOfFree
Human T-cell leukemia virus transcription modulators and screeni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human T-cell leukemia virus transcription modulators and screeni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human T-cell leukemia virus transcription modulators and screeni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-802585